期刊文献+

抗生素耐药性的起源、传播和对策 被引量:31

Origins , transfer and countermeasures of antibiotic resistances in bacteria
下载PDF
导出
摘要 细菌对抗生素产生耐药性是一种自然生物现象,抗生素的广泛应用及滥用扩大和加速了这一过程,本文就抗生素耐药性 的起源、传播和对策进行讨论,希望能有助于进一步合理应用抗生素。 The emergence of antibiotic resistance in bacteria is a natural phenomenon, which rather was expanded and accelerated by the abuse of antibiotics in clinics. Deep understanding to it will help to resolve this problem. This paper tries to discuss this issue with respect to its origin, transfer and potential countermeasures.
作者 高美英
出处 《抗感染药学》 2005年第1期1-3,共3页 Anti-infection Pharmacy
关键词 抗生素耐药性 起源 传播 合理应用抗生素 生物现象 Antibiotic resistance origins、 transfer countermeasures
  • 相关文献

参考文献10

  • 1[1]Hughes VM, Datta N. Conjugative plasmids in bacteria of the pre-antibiotic era[J]. Nature, 1983;302:725~726.
  • 2[2]Davies JE. Origins acquisition and dissemination of antibiotic resistance determinants [M]. In: Chadwick DJ. Goode J, eds.Antibiotic resistance: Origins, evolusion, selection and spread.Chichester: Wiley,1997.
  • 3华春珍,虞燕萍.结核杆菌的耐药机制[J].国外医学(流行病学.传染病学分册),2001,28(5):205-208. 被引量:2
  • 4[5]裴新树.生物进化控制论[M].北京:科学出版社,1998,223~254.
  • 5[7]Struelens MJ, Byl B, Vinccnt JL. Antibiotic policy: a tool for controlling resistance of hospital pathogens [J]. Clin Microbiol Infect, 1995,5(supple): 19 ~ 24.
  • 6[8]Hawkey, Peter M. The origins and molecular basis of antibiotic resistance[J] BMJ, 1998,317(9):657 ~ 660.
  • 7[9]巴里霍尔.对付细菌的抗药性美科学家模拟细菌进化取得成功[EB/OL].http://www. Ebiotrade.com/newsf/2002-3/L200232110364/2004-10-18.htm.
  • 8[10]里奇科文.导致细菌抗药性的遗传变异[EB/OL].Http://www.Ebiotrade.com/newsf/2002-9/L2002924101120/2004-10-18.htm.
  • 9[11]Guerrier-Takada C,Salavatl R,Altmam S.Phenotypic conversion of drug-resistant bacteria to drug sensitivity [J]. Proc Natl Acad Sci USA, 1997,94:8468 ~ 8472.
  • 10高美英,陈如,刘守桂,封江南.外源性指导序列体外转换临床大肠杆菌氯霉素抗性表型的实验研究[J].中华医学杂志,2004,84(15):1294-1298. 被引量:2

二级参考文献36

  • 1Wu H, Holcenberg JS, Tomich J, et al. Inhibition of in vitro transcription by specific double-stranded oligodeoxyribonucleotides .Gene, 1990,89:203-209.
  • 2Crooke ST. Progress toward oligonucleotide therapeutics:pharmacodynamic properties. FASEB J, 1993,7:533-539.
  • 3Weintraub HM. Antisense RNA and DNA. Scientific American,1990, 262:39-46.
  • 4Cech TR. Conserved sequences and structures of group I introns:building an active site for RNA catalysis - a review. Gene, 1998,73:259-271.
  • 5Guerrier-Takada C, Gardiner K, Marsh T , et al. The RNA moiety of ribonuclease P is the catalylic subunit of the enzyme. Cell, 1983,35:849-875.
  • 6Antony C, Forster A, Altman S. External guide sequences for an RNA Enzyme. Science, 1990,249:783-785.
  • 7Ying Li, Guerrier-Takada C, Altman S. Targeted cleavage of mRNA in vitro by RNase P from Escherichia coli. Proc Natl Acad Sci USA,1992, 89:3185-3189.
  • 8Yuan Y, Hwang E S, Altman S. Targeted cleavage of mRNA by human RNase P. Biochemistry, 1992, 28:8006-8010.
  • 9Yuan Y, Altman S. Selection of guide sequances that direct efficient cleavage of mRNA by human ribonuclease P. Science, 1994, 263:1296-1273.
  • 10Guerrier-Takada C, Ying L, Altman S. Artifical regulation of gene expression in Escherichia coli by RNase P. Proc Natl Acad Sci USA,1995,92:11115-11119.

共引文献2

同被引文献191

引证文献31

二级引证文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部